[go: up one dir, main page]

PL2474306T3 - Kompozycja w postaci cząstek stałych i zawierająca ją kompozycja lecznicza - Google Patents

Kompozycja w postaci cząstek stałych i zawierająca ją kompozycja lecznicza

Info

Publication number
PL2474306T3
PL2474306T3 PL10812082T PL10812082T PL2474306T3 PL 2474306 T3 PL2474306 T3 PL 2474306T3 PL 10812082 T PL10812082 T PL 10812082T PL 10812082 T PL10812082 T PL 10812082T PL 2474306 T3 PL2474306 T3 PL 2474306T3
Authority
PL
Poland
Prior art keywords
composition
same
particle
medicinal
medicinal composition
Prior art date
Application number
PL10812082T
Other languages
English (en)
Inventor
Yasuki Kato
Atsushi Ishii
Original Assignee
Nanocarrier Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanocarrier Co., Ltd. filed Critical Nanocarrier Co., Ltd.
Publication of PL2474306T3 publication Critical patent/PL2474306T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL10812082T 2009-08-31 2010-08-31 Kompozycja w postaci cząstek stałych i zawierająca ją kompozycja lecznicza PL2474306T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009200681 2009-08-31
EP10812082.5A EP2474306B1 (en) 2009-08-31 2010-08-31 Particle composition and medicinal composition comprising same

Publications (1)

Publication Number Publication Date
PL2474306T3 true PL2474306T3 (pl) 2017-06-30

Family

ID=43628124

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10812082T PL2474306T3 (pl) 2009-08-31 2010-08-31 Kompozycja w postaci cząstek stałych i zawierająca ją kompozycja lecznicza

Country Status (13)

Country Link
US (1) US9415059B2 (pl)
EP (2) EP2474306B1 (pl)
JP (1) JP4912510B2 (pl)
KR (1) KR101689787B1 (pl)
CN (2) CN102481255B (pl)
AU (1) AU2010287391B2 (pl)
CA (1) CA2768651C (pl)
DK (1) DK2474306T3 (pl)
ES (1) ES2614615T3 (pl)
HU (1) HUE031793T2 (pl)
PL (1) PL2474306T3 (pl)
PT (1) PT2474306T (pl)
WO (1) WO2011025036A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI568453B (zh) * 2011-11-22 2017-02-01 原創生醫股份有限公司 具有螯合型複合微胞之藥物載體及其應用
WO2016137006A1 (ja) * 2015-02-27 2016-09-01 ナノキャリア株式会社 ポリマーミセル担体組成物およびポリマーミセル組成物
CN107249560A (zh) * 2015-02-27 2017-10-13 那野伽利阿株式会社 高分子处理剂
WO2017047364A1 (ja) * 2015-09-16 2017-03-23 株式会社島津製作所 ナノ粒子およびその製造方法
JP2019060866A (ja) * 2017-09-22 2019-04-18 旭化成ファーマ株式会社 液状医薬組成物の体内動態を予測する方法
CN109134778B (zh) * 2018-08-16 2021-03-09 西南民族大学 电荷翻转型聚合物胶束、载药胶束及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940003548U (ko) 1992-08-14 1994-02-21 김형술 세탁물 건조기
TW520297B (en) 1996-10-11 2003-02-11 Sequus Pharm Inc Fusogenic liposome composition and method
TWI225412B (en) 1997-06-23 2004-12-21 Sequus Pharm Inc Liposome-entrapped polynucleotide composition and method
SE9702776D0 (sv) * 1997-07-22 1997-07-22 Pharmacia & Upjohn Ab Method of preparing pharmaceutical compositions
EP1043030A4 (en) 1997-12-26 2007-05-02 Astellas Pharma Inc MEDICINAL COMPOSITIONS WITH PROLONGED RELEASE
US6383811B2 (en) 1997-12-30 2002-05-07 Mirus Corporation Polyampholytes for delivering polyions to a cell
DE19954843C2 (de) 1999-11-09 2003-11-20 Novosom Ag Verfahren zur Verkapselung von Proteinen oder Peptiden in Liposomen, mit dem Verfahren hergestellte Liposomen und deren Verwendung
JP4659937B2 (ja) 1999-11-19 2011-03-30 ナノキャリア株式会社 コア−シェル構造のポリイオンコンプレックスミセル
GB0009773D0 (en) * 2000-04-19 2000-06-07 Univ Cardiff Particulate composition
ATE345780T1 (de) * 2001-07-13 2006-12-15 Nanocarrier Co Ltd Lyophilisierende zusammensetzung von wirkstoff- verkapselnder polymer-mizelle und verfahren zu ihrer herstellung
WO2003059382A2 (en) * 2001-12-28 2003-07-24 Supratek Pharma Inc. Pharmaceutical compositions comprising polyanionic polymers and amphiphilic block copolymers and methods of use thereof to improve gene expression
CA2518964C (en) * 2003-03-20 2011-09-13 Nippon Kayaku Kabushiki Kaisha Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer
ES2559828T3 (es) 2003-07-16 2016-02-16 Protiva Biotherapeutics Inc. ARN de interferencia encapsulado en lípidos
NZ581166A (en) * 2003-09-15 2011-06-30 Protiva Biotherapeutics Inc Polyethyleneglycol-modified lipid compounds and uses thereof
JPWO2005092389A1 (ja) 2004-03-10 2007-08-16 協和醗酵工業株式会社 複合粒子および被覆複合粒子
AU2005259799A1 (en) 2004-07-02 2006-01-12 Protiva Biotherapeutics, Inc. Immunostimulatory siRNA molecules and uses therefor
WO2006007712A1 (en) 2004-07-19 2006-01-26 Protiva Biotherapeutics, Inc. Methods comprising polyethylene glycol-lipid conjugates for delivery of therapeutic agents
JP2006056864A (ja) * 2004-08-17 2006-03-02 Yukio Nagasaki 静電結合型ポリマー修飾リポソーム薬物キャリアの供給とその使用
EP1859812B1 (en) * 2005-02-10 2014-01-01 The University of Tokyo Polycation chargeable polymer and use as carrier of nucleic acid
US20090258079A1 (en) 2005-05-10 2009-10-15 Ryoichi Katakai Biocompatible Block Copolymer, Use Thereof and Manufacturing Method Thereof
WO2007136134A1 (ja) * 2006-05-23 2007-11-29 Nanocarrier Co., Ltd. 疎水性薬物内包ポリマーミセルの製造方法
BRPI0714718B1 (pt) * 2006-07-18 2018-05-15 Nanocarrier Co., Ltd. Composição de micela polimérica de encapsulamento de polipeptídeos ou proteínas e seu método de preparo
ES2430206T3 (es) * 2006-10-03 2013-11-19 Tekmira Pharmaceuticals Corporation Formulación que contiene lípidos
CA2666697C (en) * 2006-10-19 2015-03-31 Nanocarrier Co., Ltd. Block copolymer for drug conjugates and pharmaceutical composition
US8241647B2 (en) * 2007-05-17 2012-08-14 Waseda University Amphiphilic molecule, molecular assembly comprising the amphiphilic molecule, and use of the molecular assembly
US20110268772A1 (en) * 2008-12-26 2011-11-03 Samyang Corporation Pharmaceutical composition containing an anionic drug and a production method thereof

Also Published As

Publication number Publication date
AU2010287391A1 (en) 2012-02-16
CN102481255A (zh) 2012-05-30
AU2010287391B2 (en) 2016-02-25
JPWO2011025036A1 (ja) 2013-01-31
DK2474306T3 (en) 2017-02-06
EP2474306A1 (en) 2012-07-11
JP4912510B2 (ja) 2012-04-11
HUE031793T2 (en) 2017-07-28
CA2768651A1 (en) 2011-03-03
KR20120083280A (ko) 2012-07-25
PT2474306T (pt) 2016-12-07
CN104758254A (zh) 2015-07-08
KR101689787B1 (ko) 2016-12-26
CN104758254B (zh) 2018-10-30
EP2474306B1 (en) 2016-11-09
US9415059B2 (en) 2016-08-16
CN102481255B (zh) 2015-04-22
CA2768651C (en) 2017-05-16
EP2474306A4 (en) 2013-11-27
WO2011025036A1 (ja) 2011-03-03
EP3150194A1 (en) 2017-04-05
ES2614615T3 (es) 2017-06-01
US20120107377A1 (en) 2012-05-03

Similar Documents

Publication Publication Date Title
IL253870B (en) Certain amino-pyrimidines and pharmaceutical preparations containing them
IL217912A (en) History of 5-Amino-1-Benzimidazole-Pyrazole and Pharmaceutical Preparations Containing It
EP2486918A4 (en) PHARMACEUTICAL COMPOSITION WITH BOTH IMMEDIATE AND DELAYED RELEASE
IL242883B (en) Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them
ZA201200722B (en) Pharmaceutical composition and administrations thereof
IL214911A0 (en) Solfonylated tetrahydroazolopyrazines and their use as medicinal products
IL218212A0 (en) Therapeutic methods and compositions
PL2579839T3 (pl) Kompozycje perfumeryjne i ich zastosowania
PT2474522E (pt) Agomelatina e composições farmacêuticas que contêm a mesma
PL2605757T3 (pl) Preparaty oparte na nalbufinie i ich zastosowania
PL2251006T3 (pl) Mikrocząstki i ich kompozycje farmaceutyczne
ZA201201727B (en) Indenone derivative and pharmaceutical composition comprising same
ZA201200079B (en) Pharmaceutical compositions and solid forms
PT2474306T (pt) Composição particulada e composição medicinal que a compreende
EP2445895A4 (en) DITHIOCTATE OF PIPERAZINE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
GB0908174D0 (en) Steroid containing composition and uses thereof
GB0902429D0 (en) Compositions and their use
EP2461870A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD
GB0902648D0 (en) Pharmaceutical compounds and compositions
PL2236145T3 (pl) Kompozycja farmaceutyczna i lek złożony
ZA201200260B (en) Polyphenylsulphone-polytetrafluroethylene compositions and use thereof
IL219018A (en) Radzolid Pharmaceuticals and Uses
PL2415463T3 (pl) Kompozycja lecznicza w postaci cząstek stałych
IL217137A0 (en) Medicinal and herbal composition and uses thereof
GB0908317D0 (en) Pharmaceutical compounds and compositions